Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
A combined ELISA for infection-induced and vaccine-induced mpox antibodies during the clade Ib outbreak in Rwanda: an observational, cross-sectional, clinical validation study
MpoxCARE Study Team, Clarke, J., Semukunzi, H., Faustini, S. E., Heaney, J. L. J., Kwok, H. F., Uwimana, J. M. V., Gokani, K., Rukundo, G., Musabyimana, J. P., Ingabire, P., Bitunguhari, L., de Dieu Harelimana, J., Richter, A. G., Muvunyi, C. M. & Green, C. A., 9 Mar 2026, (E-pub ahead of print) In: The Lancet Infectious Diseases.Research output: Contribution to journal › Article › peer-review
Open AccessFile3 Downloads (Pure) -
Mpox comprehensive assessment for responsive immunisation in emergency outbreaks (MpoxCARE): study protocol
Gokani, K., Semukunzi, H., Rukundo, G., Clarke, J., Faustini, S. E., Musabyimana, J. P., Roche, S., Jones, S., Otter, A. D., Richter, A., Muvunyi, C., Heaney, J., Green, C. A. & MpoxCARE Study Group, 13 Feb 2026, (E-pub ahead of print) In: BMC Infectious Diseases.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Developing accessible and affordable tests to support mpox immunosurveillance and vaccine studies
Faustini, S. E., Jones, S., Green, C. A., Otter, A. D., Richter, A. G. & Heaney, J. L., 31 Dec 2025, In: Emerging Microbes and Infections. 14, 1, 4 p., 2576581.Research output: Contribution to journal › Letter › peer-review
Open AccessFile8 Downloads (Pure) -
Effects of aerobic and resistance exercise for 9 months on serum free light chains in type 2 diabetes
Kim, Y., Campbell, J., Johannsen, N., Church, T., Cho, E., Heaney, J. & Spielmann , G., 25 Apr 2024, In: Frontiers in Physiology. 15, 13 p., 1328470.Research output: Contribution to journal › Article › peer-review
Open AccessFile31 Downloads (Pure) -
Paracetamol suppresses neutrophilic oxygen radicals through competitive inhibition and scavenging
Smith, P., Chicca, I., Heaney, J., Muchová, M., Khanim, F., Shields, A., Drayson, M., Chapple, I. & Hirschfeld, J., 1 Dec 2024, In: Chemico-Biological Interactions. 404, 8 p., 111283.Research output: Contribution to journal › Article › peer-review
Open AccessFile81 Downloads (Pure)
-
MRC IAA Follow-on: Serum/saliva Testing To Assess Protection Against Influenza Infection And Vaccination Efficacy
Richter, A. (Co-Investigator), Heaney, J. (Co-Investigator) & Faustini, S. (Principal Investigator)
1/03/26 → 30/06/26
Project: Research Councils
-
Developing a novel rapid and affordable test to enable and accelerate lupus diagnosis
Reynolds, J. (Co-Investigator) & Heaney, J. (Principal Investigator)
1/10/25 → 30/06/26
Project: Research
-
Monoclonal lateral flow for at-home MGUS (monoclonal gammopathy of undetermined significance) patient monitoring
Heaney, J. (Principal Investigator) & Faustini, S. (Co-Investigator)
CANCER RESEARCH TECHNOLOGY LTD, *New Funder - Charity*
1/02/25 → 1/08/26
Project: Research
-
Early detection of relapse of multiple myeloma in patients with high risk genetics (RADAR)
Richter, A. (Principal Investigator) & Heaney, J. (Co-Investigator)
1/02/25 → 31/01/28
Project: Research
-
Progressing 4 antibody multiplex Lateral flow assay for Diabetes (Diabetes 4ward)says to design freeze
Heaney, J. (Co-Investigator), Narendran, P. (Co-Investigator), Faustini, S. (Co-Investigator) & Richter, A. (Principal Investigator)
1/08/24 → 30/06/26
Project: Research
Activities
- 2 Guest lecture or Invited talk
-
Diagnosing and monitoring myeloma using serum free light chain tests
Heaney, J. (Invited speaker)
31 Jan 2018Activity: Academic and Industrial events › Guest lecture or Invited talk
-
NIHR-efficacy and mechanism and evaluation (EME) project: Investigating interactions between the triad of (I) Myeloma disease activity, (II) Immune-competence (iii) Infections and Health Care Associated Infections to stratify patients for risk of infection, guide use of prophylactic antibiotics and improve response to anti-myeloma therapies
Heaney, J. (Chair)
21 Nov 2017Activity: Academic and Industrial events › Guest lecture or Invited talk